Skip to Main Content

Paper Details

Identification of Schlafen-11 as a Target of CD47 Signaling That Regulates Sensitivity to Ionizing Radiation and Topoisomerase Inhibitors.
Front Oncol
19
2019
CD47, CD47 function-blocking antibody, CD47 mRNA, CD47-deficient Jurkat cells, CD47-deficient T cells, H2AX, H3, Jurkat T cells, Jurkat cells, PC3 cells, PC3 prostate cancer cells, SLFN11, SLFN11 promoter, SLFN11 promoter region, Schlafen, Schlafen-11, Topoisomerase, cancers, etoposide, histone, histone deacetylase, human, non-malignant cells, non-malignant tissues, schlafen, schlafen-11, schlafen-11 mRNA, thrombospondin-1, topoisomerase, topoisomerases, tumors
Author NameAffiliation
Abdel G ElkahlounNational Human Genome Research Institute, National Institutes of Health
Craig J ThomasNational Center for Advancing Translational Sciences, National Institutes of Health
Marc FerrerNational Center for Advancing Translational Sciences, National Institutes of Health
Vinodh N RajapakseCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Yves PommierCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Yves PommierCenter for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 6

Datasets

Release 1.2